Strata Skin Sciences, Inc. (SSKN) Shares Up 8.3%
Strata Skin Sciences, Inc. (NASDAQ:SSKN) shares were up 8.3% during trading on Wednesday . The stock traded as high as $1.70 and last traded at $1.30. Approximately 1,116,300 shares changed hands during mid-day trading, an increase of 802% from the average daily volume of 123,818 shares. The stock had previously closed at $1.20.
Several research analysts have commented on SSKN shares. HC Wainwright set a $12.00 price objective on Strata Skin Sciences and gave the company a “buy” rating in a research report on Wednesday, October 18th. Zacks Investment Research downgraded Strata Skin Sciences from a “hold” rating to a “sell” rating in a research note on Wednesday, August 16th. Finally, ValuEngine downgraded Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a research note on Monday, October 2nd.
The company has a current ratio of 1.64, a quick ratio of 0.93 and a debt-to-equity ratio of 0.37.
WARNING: “Strata Skin Sciences, Inc. (SSKN) Shares Up 8.3%” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.watchlistnews.com/strata-skin-sciences-inc-sskn-shares-up-8-3/1709023.html.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.